HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.

This study has been completed.
Sponsor:
Collaborators:
GlaxoSmithKline
Asociación Civil Impacta Salud y Educación, Peru
Information provided by:
University of Washington
ClinicalTrials.gov Identifier:
NCT00378976
First received: September 19, 2006
Last updated: August 21, 2013
Last verified: August 2013